Agilent Technologies stock holds steady as business context matters

Agilent Technologies (ISIN US00846U1016) is a Nasdaq-listed life sciences and diagnostics company whose business spans analytical instruments, diagnostics, and laboratory workflow tools.

Business profile

Agilent Technologies, Inc. operates across three main areas: life sciences and applied markets, diagnostics and genomics, and Agilent CrossLab. That structure gives the company exposure to research labs, biopharma, and clinical testing demand rather than a single end market.

Market context

For investors, that mix matters because Agilent's revenue base is tied to recurring consumables and service activity as well as instrument sales. The company trades on Nasdaq in U.S. dollars, which keeps it firmly in the U.S. large-cap market conversation.

Agilent's core products

Representative products include liquid chromatography systems, mass spectrometry platforms, and diagnostics assays used in laboratories and testing facilities. Those offerings anchor the company in instrument replacement cycles and ongoing consumables demand.

Stock level

Agilent Technologies stock is listed on Nasdaq under A, with the company positioned as a U.S. life sciences and diagnostics name.